Diagnosis and treatment of Multiple Sulfatase Deficiency and other using a Formylglycine Generating Enzyme (FGE)

Details for Australian Patent Application No. 2004210936 (hide)

International Classifications

Event Publications

18 August 2005 PCT application entered the National Phase

PCT publication WO2004/072275 Priority application(s): WO2004/072275

7 June 2007 Change of Name(s) of Applicant(s), Section 104

Transkaryotic Therapies, Inc. The name of the applicant has been changed to Shire Human Genetic Therapies, Inc.

13 May 2010 Application Accepted

Published as AU-B-2004210936

12 August 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 20 Jul 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

2 December 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Jul 2010

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.